Showing results (11-20 of 170) with videos related to
Sort By:
Pageof 17
Critical Reviews in Oncology/Hematology|December 13, 2019
Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemiaHikmat Abdel-Razeq, Hasan HashemFrontiers in Oncology|October 20, 2023
Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4/6 inhibitors beyond progressionMalek Horani, Hikmat Abdel-RazeqOncotargets and Therapy|August 4, 2022
Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline VariantsSarah Edaily, Hikmat Abdel-RazeqDrug Design, Development and Therapy|March 24, 2022
Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant SettingHikmat Abdel-Razeq, Baha' SharafTherapeutics and Clinical Risk Management|July 15, 2011
Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approachHikmat Abdel-Razeq, Yousef IsmaelJournal of Thrombosis and Thrombolysis|September 2, 2017
Venous thromboembolism prophylaxis for ambulatory cancer patients, can we do better?Hikmat Abdel-Razeq, Asem MansourJournal of Cancer Research and Therapeutics|November 3, 2011
Bone health in breast cancer survivorsHikmat Abdel-Razeq, Abdulla AwidiBiologics : Targets & Therapy|August 18, 2011
Current neoadjuvant treatment options for HER2-positive breast cancerHikmat Abdel-Razeq, Lina MareiWorld Journal of Oncology|January 5, 2026
Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic VariantsHikmat Abdel-Razeq, Razan MansourCancers|May 11, 2024
Challenges and Opportunities in Breast Cancer Care in Low-Resourced Countries, Jordan as An ExampleHikmat Abdel-Razeq, Asem MansourPageof 17